The Connect Trial: Connecting Hospital Patients to Alcohol Care

Condition(s) studied

Investigational drug(s) / intervention(s)

AUD treatment sessions with an outreach alcohol therapist at the hospital: Participants will be offered an AUD treatment session at the hospital the same or next day as they are enrolled in the study with an outreach alcohol therapist from a local AUD treatment facility. The alcohol therapist will be trained in motivational interviewing and cognitive behavioural therapy for AUD. The session will aim to motivate patients to reduce their alcohol consumption and set goals for AUD treatment. The alcohol therapist can recommend a medical therapy to support alcohol reduction or abstinence - this prescription will be undertaken by a hepatologist from the Department of Medicine and may be continued after discharge by patients´ general practitioner or physicians at the AUD treatment facility. Up to 10 sessions of up to 60 minutes of duration at the hospital during 6 months after the baseline visit can be offered and after that, the participant can continue to meet with the same therapist in the community.

Guidance and leaflet on AUD treatment facilities outside the hospital: Participants randomised as controls will be offered a leaflet informing about different possibilities for alcohol misuse treatments and guidance on how to approach them (may include referral or help with doing an appointment, if possible according to the specific treatment center) in the catchment area of SUH Køge and Roskilde

Study summary

The main objective of this pilot study is to assess feasibility of conducting a definitive RCT with concealed allocation, blinded outcome assessment and a 1:1 parallel group design of A) an invitation to meet an AUD therapist for up to 10 treatment sessions at the hospital in up to 6 months (intervention) compared to B) guidance on how to seek alcohol care in an AUD treatment centre in the community, outside of the hospital (control).

Eligibility

Primary outcome measure(s)

• Recruitment — 6 months
  \>50% of eligible individuals invited to the study give written informed consent
• Retention — 6 months
  \>50% individuals recruited and randomized to the intervention, will attend to the intervention of seing the AUD therapist at least once
• Completion — 6 months
  \>50% of all randomized study participants complete the follow-up interview and blood sample

Trial sites (1)

More Zealand University Hospital trials in Denmark

Other trials for the same condition